Israel’s prime minister has announced that the country will offer a coronavirus booster jab to people over 60 who have already been vaccinated. The announcement by Naftali Bennett makes Israel, which launched one of the world’s most successful vaccination drives early this year, the first country to offer a third dose of a Western vaccine to its citizens on a wide scale.
About 13 percent of Australians have been vaccinated, with low supplies of Pfizer-BioNTech shots and scepticism about the AstraZeneca jab. Millions of Sydney residents will spend another month in lockdown, authorities announced Wednesday, citing a still-growing coronavirus outbreak and low vaccination rates. Australia's biggest city had been due to exit lockdown on July 30 after five weeks but the restrictions will remain in place until August 28 as case numbers continued to climb.
CAPE TOWN, South Africa: A South African pharmaceutical company will manufacture the Pfizer- BioNTech Covid vaccine for distribution in Africa. The South African biopharmaceutical manufacturer Biovac reached agreement to produce the Pfizer COVID-19 vaccine for distribution in Africa. The continent of Africa has, to date, inoculated a little more than 3 percent of its population with at least one shot.
From: Stella LockyerMicheldene Road, East Dean I found some very suspect leaflets questioning coronavirus vaccination on my car parked in Exceat car park. How can these people, purporting to be doctors, be allowed to spread such appalling rubbish? Proof of the Covid vaccines’ efficacy and safety are in the news every day, with far fewer people becoming dangerously ill after bring vaccinated.
The London area health unit is reminding parents that students aged 12 to 17 who want to be fully immunized by the start of the school year must get their first COVID-19 shot by Saturday. London-area COVID-19 vaccination clinics are open to walk-ins and people from other jurisdictions, the city’s top doctor says.
(Reuters) - South Africa's Biovac Institute is aiming to start production of the mRNA COVID-19 vaccine developed by Pfizer and BioNTech in the second half of next year, its chief executive officer said on Wednesday. Morena Makhoana told Reuters the Cape Town-based firm would ramp up production of the COVID-19 vaccine before reaching output of 100 million doses a year around early 2023.
Fewer than one in 12 people reported negative side effects in the week after having a coronavirus vaccine, while almost half reported feeling better, a study has indicated. Some 7.9 per cent of participants reported side effects that disrupted their daily activities, with the most common including fever, headaches and fatigue, according to the Vac4Covid study that recruited more than 12,000 people across the UK.
CHICAGO, July 20 (Reuters) - Scientists are working on a benchmark for COVID-19 vaccine efficacy that would allow drugmakers to conduct smaller, speedier human trials to get them to market and address a huge global vaccine shortage. Researchers are trying to determine just what level of COVID-19 antibodies a vaccine must produce to provide protection against the illness.
It's only a maybe for now. Israel has begun giving a third dose of the COVID-19 vaccine developed by Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) to some adults. The decision was made after COVID-19 cases began to surge in the country due to the spread of the delta variant.
As the coronavirus continues to spread across the country, there are frequent reports of fully vaccinated people contracting COVID-19. Experts say these "breakthrough cases" are expected, and want to assure people the vaccines are still highly effective. Clinical trial data showed that the Pfizer-BioNTech, Moderna and Johnson & Johnson coronavirus vaccines were extremely effective in preventing disease, but Dr. Bill Moss, a pediatrician and professor of infectious disease epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, noted that some people in the trials did contract the virus.
Nadhim Zahawi tells Kay Burley he will set out the latest in a Commons statement to MPs from around 3.30pm. The vaccines minister has told Sky News he will provide an update on coronavirus jabs for children aged between 12 and 17 later on Monday. Nadhim Zahawi told Kay Burley he will set out the latest in a Commons statement to MPs from around 3.30pm.
Researchers in the United States have conducted a study showing that the coronavirus disease 2019 (COVID-19) vaccines developed by Pfizer-BioNTech and Moderna generate a coordinated adaptive immune response that is capable of eliciting recall responses to future infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Brit kids ‘will only get Covid jabs if they’re vulnerable as ministers shun mass vaccinations amid scientists’ fears’
BRIT kids will only get Covid jabs if they’re vulnerable as ministers shun plans for mass vaccinations amid scientists’ fears, it has been reported. Ministers are said to be preparing to offer doses to vulnerable 12 to 15-year-olds and those about to turn 18. The jabs will also be offered to kids aged between 12 and 15 who live with adults who are immunosuppressed or whose health is otherwise at risk from the coronavirus, the Telegraph reports.
Current evidence suggests the COVID-19 vaccines administered in the U.S. are still highly effective against the delta variant. People who are fully vaccinated against COVID-19 in the U.S. are strongly protected against the highly transmissible delta variant of the coronavirus, and do not need booster shots yet, according to experts.
PARIS, July 16 (Reuters) - France reported more than 10,000 new coronavirus cases again as the rapid spread of the more contagious Delta variant led to a jump in new infections. The health ministry reported 10,908 new cases on Friday, taking the total to more than 5.84 million.
Israeli government says Pfizer's COVID-19 vaccine provides 'significantly less' protection against the Indian 'Delta' variant than health officials had hoped
Israel says the Pfizer-BioNTech COVID-19 vaccine is 'weaker' against the Indian 'Delta' variant and provides 'significantly less' protection than hoped The country, which once led the world in the vaccine race, said new data show the two-dose shot provides just 64% protection against infection The variant now makes up more than 80% of all samples sequenced in Israel as it deals with a surge in cases
SINGAPORE (Reuters) - Sinovac's COVID-19 vaccine, under growing scrutiny over its effectiveness, has found a small but determined group of takers in Singapore - even though the country does not count them as being vaccinated in its official tally. Singapore provides the more effective mRNA shots from Pfizer-BioNTech and Moderna free under its national vaccination programme but thousands have chosen to pay as much as S$25 ($18.5) for Sinovac's CoronaVac.
Breakthrough infections? Rising cases? What to know about the recent COVID-19 trends in Massachusetts.
“These numbers show the reason to get vaccinated." For the first time in months, COVID-19 trends in Massachusetts seem to be trending, if slightly, in the wrong direction. Infections and even hospitalizations due to COVID-19 have begun to increase since the Fourth of July weekend.
The local health board have announced effective from today they are bringing forward the second dose interval for both the Pfizer and AstraZeneca vaccine from eight to six weeks. The details came as Gill Harris, Executive Director of Nursing and Midwifery at Betsi Cadwaladr University, gave a wide ranging update, “This week we have reached the significant milestone of fully vaccinating 400,000 eligible adults in North Wales.